Assessing Medication Consultations, Hypertension Control, Awareness, and Treatment Among Elderly Asian Community Dwellers Research and Reports
Objective: To describe blood pressure (BP) and medication-related findings of a pharmacist-conducted hypertension (HTN) monitoring program.
Study design: Retrospective post hoc analysis.
Setting: Community site.
Patients: Multiethnic, community-dwelling, Asian older adults.
Interventions: Medication consultation/BP records from 1998-2005 were reviewed. Participants' mean baseline BP readings were classified using guidelines from the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) and stratified into three groups: ≤ 70, 71-79, and ≥ 80 years of age. Medication consultations were grouped into: lifestyle/general medication review, adherence assessment, non-HTN medication consults, and specific consults, which included pharmacist-provided, medication-related recommendations. Participants with specific consults and subsequent self-reported changes in HTN therapy were identified. Their mean BP readings at six months, before and after the self-reported changes, were assessed for differences, using paired t-test, P ≤ 0.05 was significant.
Main Outcome Measures: Baseline HTN treatment/awareness rates, age-stratified HTN control, number/types of HTN medications used, adherence problems, consultations provided, BP changes in participants who self-reported changes in medication therapy.
Results: Among 414 participants (averaged 74.2 ± 8.5 years of age, 34.1% male), baseline HTN rate, awareness rate, and treatment rates were 51.9%, 37.9%, and 24.9%, respectively. Baseline BP worsened with increasing age. Overall, 258 participants received 651 consultations. The most prevalent nonadherent behavior reported was selfadjustment of medication dosing. Among 65 participants who received HTN medication-related advice, 52/65 (80%) reported changes in medication therapy and showed significant improvement in BP at six months before and after the self-report.
Conclusion: HTN awareness/treatment rates were low in the entire population. HTN control was worst among the oldest individuals. Implementing initiation or adjustments in medication therapy can potentially improve BP control.
Abbreviations: BP = Blood pressure, BRFSS = Behavioral Risk Factor Surveillance System, CDC = Centers for Disease Control and Prevention, DBP = Diastolic blood pressure, HTN = Hypertension, JNC = Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NHANES = National Health and Nutrition Examination Survey, OTC = Over-the-counter, SBP = Systolic blood pressure. Consult Pharm 2008;23:795-803.
Study design: Retrospective post hoc analysis.
Setting: Community site.
Patients: Multiethnic, community-dwelling, Asian older adults.
Interventions: Medication consultation/BP records from 1998-2005 were reviewed. Participants' mean baseline BP readings were classified using guidelines from the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) and stratified into three groups: ≤ 70, 71-79, and ≥ 80 years of age. Medication consultations were grouped into: lifestyle/general medication review, adherence assessment, non-HTN medication consults, and specific consults, which included pharmacist-provided, medication-related recommendations. Participants with specific consults and subsequent self-reported changes in HTN therapy were identified. Their mean BP readings at six months, before and after the self-reported changes, were assessed for differences, using paired t-test, P ≤ 0.05 was significant.
Main Outcome Measures: Baseline HTN treatment/awareness rates, age-stratified HTN control, number/types of HTN medications used, adherence problems, consultations provided, BP changes in participants who self-reported changes in medication therapy.
Results: Among 414 participants (averaged 74.2 ± 8.5 years of age, 34.1% male), baseline HTN rate, awareness rate, and treatment rates were 51.9%, 37.9%, and 24.9%, respectively. Baseline BP worsened with increasing age. Overall, 258 participants received 651 consultations. The most prevalent nonadherent behavior reported was selfadjustment of medication dosing. Among 65 participants who received HTN medication-related advice, 52/65 (80%) reported changes in medication therapy and showed significant improvement in BP at six months before and after the self-report.
Conclusion: HTN awareness/treatment rates were low in the entire population. HTN control was worst among the oldest individuals. Implementing initiation or adjustments in medication therapy can potentially improve BP control.
Abbreviations: BP = Blood pressure, BRFSS = Behavioral Risk Factor Surveillance System, CDC = Centers for Disease Control and Prevention, DBP = Diastolic blood pressure, HTN = Hypertension, JNC = Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NHANES = National Health and Nutrition Examination Survey, OTC = Over-the-counter, SBP = Systolic blood pressure. Consult Pharm 2008;23:795-803.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics
Keywords: Asian; Blood pressure; Community-dwelling; Elderly; Hypertension; Medication consultation; Multiethnic; Older adults
Document Type: Research Article
Publication date: 01 October 2008
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- ">

- Ingenta Connect is not responsible for the content or availability of external websites